Artificial Insemination Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Artificial Insemination Market: By Product Type (Insemination Kits, Home Conception Devices, Accessories), By Procedure Type (Intravaginal Insemination, Intracervical Insemination, Intrauterine Insemination, and Intratubal Insemination), By End User (Hospitals and Clinics, Fertility Centers, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Artificial Insemination Market size was valued at USD 2.1 billion in 2021, growing at a CAGR of 8.4% during 2022-2028. In order to cure infertility, a procedure known as artificial insemination involves placing semen directly into a woman’s womb. The aim of this treatment is to directly inject cleaned sperm into the uterus, cervix, or fallopian tubes using a thin, flexible foley catheter that is inserted through the cervix. This can then lead to pregnancies in women who were previously unable to get pregnant for various reasons. Intrauterine insemination is another name for this procedure in medicine. Due to the increased incidence of infertility problems in both males and females, broad technology breakthroughs in the medical field, and rising healthcare costs across the globe, this market vertical is experiencing profitable growth.

 

The Artificial Insemination Market Key Developments:

In 2016, Worthington Industries, collaborated with Intellectual Ventures and launched AIS 3 and AIS 1.5 artificial insemination shield refrigerators holding samples.

 

 

Artificial Insemination Market

MARKET SUMMARY
-
8.4%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 8.4%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Artificial Insemination Market

  • The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, procedure type, end user, and region.
  • This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • Key stakeholders of the market include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global artificial insemination products.
Key Players
  • Kitazato Corporation
  • Bescot Healthcare
  • Church & Dwight Co., Inc.
  • Nikon Instruments Inc.
  • Worthington Industries
Artificial Insemination Market Dynamics

Increase in the prevalence of infertility among the men and women is a major factor surge the growth of artificial insemination market over the forecast years. Increase in the prevalence of infectious diseases, genetic issues, and unhealthy lifestyle are the major factors enhance the infertility among the population. For instance, according to National Survey of Family Growth approximately 15.5% of female population intended to become pregnant are infertile. In addition, as per Center for Disease Control and Prevention, approximately 6.1 Mn female aged between 15-44 years are infertile in USA. Furthermore, development of advanced insemination kits by the market players also surge the market over the forecast timeframe.


North-America Got Significant Share

Artificial Insemination Market

Global artificial insemination market report gives comprehensive outlook on artificial insemination across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America expected to dominate the market by 2025 owing to increase in the prevalence of infertile prevalence in USA and Canada, increase in the adoption of technological advanced procedures, sophisticated healthcare infrastructure, and favorable reimbursement policies present in the region. Moreover, Europe artificial insemination market contributed highest growth rate in 2019 and expected to grow at 5.6% CAGR over the forecast years owing to increase in research and development on newer procedures, unhealthy lifestyle, and adoption of advanced technologies in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Artificial Insemination Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Vitrolife
  • Genea Limited
  • Kitazato Corporation
  • Bescot Healthcare
  • Church & Dwight Co., Inc.
  • Kate & Duck
  • Insemination Supplies, LLC
  • Zander scientific Inc.
  • Conceivex, Inc.
  • TenderNeeds Fertility
  • Biogenics Inc.
  • Hamilton Throne Ltd.
  • Rinovum Women’s Health, LLC
  • Pride Angel
  • Nikon Instruments Inc.
  • Worthington Industries

Description

Artificial Insemination Market size was valued at USD 2.1 billion in 2021, growing at a CAGR of 8.4% during 2022-2028. In order to cure infertility, a procedure known as artificial insemination involves placing semen directly into a woman’s womb. The aim of this treatment is to directly inject cleaned sperm into the uterus, cervix, or fallopian tubes using a thin, flexible foley catheter that is inserted through the cervix. This can then lead to pregnancies in women who were previously unable to get pregnant for various reasons. Intrauterine insemination is another name for this procedure in medicine. Due to the increased incidence of infertility problems in both males and females, broad technology breakthroughs in the medical field, and rising healthcare costs across the globe, this market vertical is experiencing profitable growth.

 

The Artificial Insemination Market Key Developments:

In 2016, Worthington Industries, collaborated with Intellectual Ventures and launched AIS 3 and AIS 1.5 artificial insemination shield refrigerators holding samples.

 

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX